Transaction

Masters Pharmaceuticals Investment

Albion Ventures has invested £2.65m in Masters Pharmaceuticals Ltd (Masters) as sole investor. Masters is a specialist international supplier and distributor of pharmaceutical products and the investment will be used for continued expansion in its core markets of Latin America, the Middle East and the Caribbean. Masters is also seeking to open new markets in Asia.

Peter Counsell of Meta Corporate Finance advised the existing shareholders, including the founder Zulf Masters, on the investment from Albion Ventures.

Masters was founded in 1984 and operates primarily in the international supply of licensed drugs into unlicensed territories providing access for international markets to drugs that are commonly available in the US and Europe but hard to access from outside those markets. Other activities are centred on specialist wholesale distribution of generic and branded pharmaceuticals.

Masters has appointed Bill Burns as non-executive chairman of its board. Bill is a high profile figure in the pharmaceutical industry with over forty years experience in the sector most recently as CEO of Roche Pharmaceuticals and will build on Masters’ current strong organic growth through targeted acquisition and partnering opportunities.

Andrew Elder, Partner, Albion Ventures said, “Masters is an attractive investment for us because it operates within a global market that is experiencing a huge increase in demand for leading US and European drugs and treatments. There is real potential for it to become the market leader in this space and the appointment of Bill Burns adds real depth to an already talented and experienced management team.”

Client:

Masters Pharmaceuticals

Service:

Sell Side

Region:

International

Sector:

Healthcare & Pharmaceuticals

META Project Lead

Peter Counsell

NEED MORE INFORMATION?

Get in touch with our team today

Interested in our services or have any questions?

Latest Transactions

Check out our latest Transactions

Testimonials

What our clients have said

“We are happy that KnowledgePool will drive forward our objectives for Maxim far faster than we may have been able to alone. Meta’s strategic and corporate finance advice enabled us to present our case to KnowledgePool in the best possible light and for us, as shareholders, to realise the value we all knew was embedded in our product base.”

Chris Brand

Maxim Training

“I worked with Mark at Meta over an extended period. Their hands-on approach helped me formulate a strategy to maximise the value of my business and to identify the right partner to ensure its success.”

Michael Brett

Revive

"The advice that Peter at Meta gave us throughout was vital to the ultimate completion. We are delighted to complete the buy-out and look forward to life as an independent business."

Derek Kenny

Erith Waste

“We are very grateful to Peter Counsell for his experienced support during the negotiations. He understood the nature of ITUK and its philosophy and skilfully guided us through the maze of issues that are inherent in such a complex transaction. Meta had a very difficult role as they were heavily involved in negotiating in two cultures."

Nikki King

Isuzu

“I am very happy to see Murston Plant now under GSE’s ownership. The negotiations proceeded in a very professional manner, as you would expect, but this was aided significantly by Peter Counsell’s role as lead adviser. He maintained an air of calm that helped the transaction move to a successful conclusion.”

Roy Allan

Murston Plant

“This was a complex transaction, handled with great skill by Peter Counsell at Meta. We had to find a structure that accommodated the requirements of the exiting, ongoing and incoming shareholders and of the funders. Peter’s experience in building such structures and his knowledge of the funding market was vital to the achievement of those requirements.”

Tim Mann

The Brantham Group